Spring Creek Capital’s Acceleron Pharma XLRN Stock Holding History

Spring Creek Capital’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-80,000	Closed	-$13.8M	–	746
2021 Q3	$13.8M	Buy	+80,000	New	+$10.5M	0.67%	27

Spring Creek Capital's XLRN Position: Q4 2021 in Review

Spring Creek Capital sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 80,000 shares — an estimated $13.8M sold.

Spring Creek Capital first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $13.8M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Spring Creek Capital reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Spring Creek Capital sold 80,000 Acceleron Pharma shares in Q4 2021, an estimated $13.8M.
Spring Creek Capital first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
Spring Creek Capital's Acceleron Pharma position peaked at $13.8M in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Spring Creek Capital's 13F filing for Q4 2021, filed 11 Feb 2022.